theory clinical_107_2
imports Main

begin

typedecl entity
typedecl event

consts
  Overexpression :: "entity ⇒ bool"
  HER2V777LMutation :: "entity ⇒ bool"
  Resistance :: "entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"
  Assay :: "entity ⇒ bool"
  SoftAgarColonyFormation :: "entity ⇒ bool"
  ColorectalCancerCellLine :: "entity ⇒ bool"
  Result :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "entity ⇒ bool"
  AntiHER2AntibodyTherapy :: "entity ⇒ bool"
  Develop :: "event ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  TrastuzumabTherapy :: "entity ⇒ bool"
  Treatment :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  Source :: "event ⇒ entity ⇒ bool"
  Tumor :: "entity ⇒ bool"
  Method :: "event ⇒ entity ⇒ bool"

(* Explanation 1: Overexpression of a HER2 V777L mutation resulted in trastuzumab resistance by a soft-agar colony formation assay of a colorectal cancer cell line. *)
axiomatization where
  explanation_1: "∃x y z e. Overexpression x ∧ HER2V777LMutation x ∧ Resistance y ∧ Trastuzumab y ∧ Assay z ∧ SoftAgarColonyFormation z ∧ ColorectalCancerCellLine z ∧ Result e ∧ Agent e x ∧ Patient y ∧ Method e z"

(* Explanation 2: A portion of tumors in patients ultimately develop resistance to anti-HER2 antibody therapy, including Trastuzumab. *)
axiomatization where
  explanation_2: "∃x y z e. Tumor x ∧ Patient y ∧ Resistance z ∧ AntiHER2AntibodyTherapy z ∧ Trastuzumab z ∧ Develop e ∧ Agent e x ∧ Patient z ∧ In x y"

(* Explanation 3: Patients with tumors that develop resistance to anti-HER2 antibody therapy are likely to develop resistance to Trastuzumab therapy. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2. Patient x ∧ Tumor y ∧ Resistance z ∧ AntiHER2AntibodyTherapy z ∧ Develop e1 ∧ Agent e1 y ∧ Patient z ∧ Resistance w ∧ TrastuzumabTherapy w ∧ Develop e2 ∧ Agent e2 x ∧ Patient w"

(* Explanation 4: Patients who develop resistance to anti-HER2 antibody therapy may also develop resistance to Trastuzumab therapy. *)
axiomatization where
  explanation_4: "∃x y z w e1 e2. Patient x ∧ Resistance y ∧ AntiHER2AntibodyTherapy y ∧ Develop e1 ∧ Agent e1 x ∧ Patient y ∧ Resistance z ∧ TrastuzumabTherapy z ∧ Develop e2 ∧ Agent e2 x ∧ Patient z"

(* Explanation 5: Patients may benefit from treatment with Trastuzumab. *)
axiomatization where
  explanation_5: "∃x y e. Patient x ∧ Treatment y ∧ Trastuzumab y ∧ Benefit e ∧ Agent e x ∧ Source e y"

theorem hypothesis:
  assumes asm: "Patient x"
  (* Hypothesis: This patient may develop resistance to Trastuzumab therapy. *)
  shows "∃x y e. Patient x ∧ Resistance y ∧ TrastuzumabTherapy y ∧ Develop e ∧ Agent e x ∧ Patient y"
  using explanation_4 by auto
  

end
